Clinical Trials on Antifungal Agents in India

Total 10 results

GlaxoSmithKline

Completed

Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions

Antifungal Agents

India
Fortis Hospital, India
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Clinical Outcome in High Risk Patients Who Received Empirical Antifungal Therapy

Antifungal Therapy

India
Postgraduate Institute of Medical Education and...

Recruiting

Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients

Acute-On-Chronic Liver Failure | Mycoses | Invasive Fungal Infections | Antifungal Agents

India
Dr. Krupa NC

Completed

Anticaries Effect of Xylitol,Probiotic and Chlorhexidine Mouth Rinses Among Individuals at High Risk (AEXPC)

Cariostatic Agents | Mouthwashes

India
Postgraduate Institute of Medical Education and...

Unknown

HCV RAS Testing in Public Health Programs (RAS-HCV)

Hepatitis C | Public Health | Direct Acting Antiviral Agents | Resistance Associated Substitutions

India
Jyoti Clinical and Pathological Laboratory

Completed

Evaluation of Safety and Efficacy of Mersina, an Ayurvedic Formulation: A Double Blind, Placebo Controlled Study in Type 2 Diabetic Patients With Secondary Failure to Oral Drugs

Antihyperglycemic Effect in Type 2 Diabetic Patients With Secondary Failure to Oral Hypoglycemic Agents

India
Indian Council of Medical Research
King George's Medical University; Lady Hardinge Medical College; Postgraduate... and other collaborators

Completed

7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis

Recurrence | Anti-bacterial Agents | Neonatal SEPSIS | Infant, Newborn

India
Bayer

Active, not recruiting

Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)

Coronary Artery Disease (CAD) | Prevention of Atherothrombotic Events | Symptomatic Peripheral Artery Disease (Symptomatic PAD)

India
Novartis Pharmaceuticals

Terminated

A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People (APOLLO)

Cardiovascular Events

Colombia, India, South Africa, Canada, Spain, Hungary, United States, Germany, Ireland, Argentina, Philippines, Brazil, Sweden, Malaysia, Chile, Israel, Czech Republic, Netherlands
Sanofi

Terminated

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation (BOREALIS-AF)

Atrial Fibrillation

South Africa, Thailand, Chile, Guatemala, Ukraine, United States, Argentina, Australia, Austria, Belarus, Brazil, Bulgaria, Canada, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Greece, India, ... and more

Clinical Trials on Antifungal Agents in India

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations